OGI NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

OrganiGram Holdings Inc · Healthcare · Drug Manufacturers - Specialty & Generic

Open interactive chart View report data
Latest close 0.94 USD
0.5% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -26.6% below the Trend Line and sits at 6.2% of its 52-week range. The latest completed week returned 0.5%, after a -8.8% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 53/100 conviction, while the latest news-sentiment score is 52/100. Near-term considerations: volume confirmation is below normal; earnings are due in 10d.

Setup score 16 out of 100
Latest Close 0.94 USD 31 Jul 2026
1W Return 0.5% latest completed week
4W Return -8.8% short-term follow-through
12W Return -30.9% quarterly tape
Trend Breadth 48.1% 25 of 52 weeks active
Volume Ratio 0.3x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 0.5% Latest completed week; four-week move -8.8%. Indicator stack 26/15 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 53/100 conviction; expected move 13.9%. News sentiment 52/100 58 relevant articles in the latest sentiment read. Event risk 10d Next report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -26.6% below the Trend Line and sits at 6.2% of its 52-week range. The latest completed week returned 0.5%, after a -8.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.3x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0112-week average 0.02

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.01Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -8.8% over four weeks, -30.9% over 12 weeks, and -29.4% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W0.5%
4W-8.8%
12W-30.9%
26W-37.4%
52W-29.4%
Active trend streak0 weeks
Active weeks in one year25
Trend breadth48.1%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-1.82Latest activity-pressure read.
Pressure change-27.4%Four-week change in activity pressure.
Leadership-41.69Latest relative-leadership reading.
RS change-2.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 88% Model confidence 84%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength37/100Blend of value, momentum, and quality. Underlying universe rank 64; rank 1 is best.
Value80/100Relative valuation strength. Underlying universe rank 21; rank 1 is best.
Quality5/100Profitability and accounting quality. Underlying universe rank 96; rank 1 is best.
Momentum9/100Medium-term price momentum. Underlying universe rank 92; rank 1 is best.
Growth85/100Revenue and earnings growth. Underlying universe rank 16; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.5x
Market value relative to trailing revenue.
EV / EBITDA
15.2x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
4.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
35.6%
Gross profit retained from each unit of revenue.
Operating margin
-5.2%
Operating profit retained from revenue.
Free-cash-flow margin
1.4%
Free cash flow generated from revenue.
Return on invested capital
-3.2%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
41.2%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
2/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-31.3%
Net share repurchases relative to market value.
Shareholder yield
-31.3%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-8.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

OGI shows volatility options pressure with a 53/100 conviction score, put-call volume ratio of 0.08, expected move of 13.9%, and Sharemaestro trend signal inactive.

Conviction53/100
Expected move13.9%
Put/call volume0.08
Pressure96
Speculation12
Volatility96
Trend agreement0
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment52/100

Weighted news tone is neutral across 58 relevant articles.

14 positive · 38 neutral · 6 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings10dNext report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
Options expected move13.9%Nearest-chain priced movement where available.
52-week drawdown-58.1%Distance below the 52-week high.
13-week volatility7.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2613 weeks finished lower.
Best week+11.6%Week of 20 Feb.
Worst week-21.3%Week of 15 May.
Latest week+0.5%Week of 31 Jul.

Shape of recent returns

Strong gains5
Modest gains6
Flat weeks2
Modest losses5
Sharp losses8
Recent vol7.2%13-week weekly-return volatility.
Base vol7.1%52-week weekly-return volatility.
Up/down split23/27Count of positive and negative weeks in the 52-week window.
Average skew5.7% / -5.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape19/100

Trend, activity pressure, participation, and risk combine to a 19/100 tape read.

 Indicator analysis9/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.01; No reversal markers Factors32/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Tiny Titans rank 55; Buyback Yield rank 94; Small Cap Core rank 38 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options36/100

OGI shows volatility options pressure with a 53/100 conviction score, put-call volume ratio of 0.08, expected move of 13.9%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 13.9% Sentiment52/100

Weighted news tone is neutral across 58 relevant articles.

Organigram Global Inc Insiders50/100

No recent insider transaction evidence is stored.

 Earnings10d

Next report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20260.94 USD0.5%1.28 USD1.52 USD-1.82-41.69938.2KOff
24 Jul 20260.93 USD3.9%1.31 USD1.52 USD-1.74-42.151.0MOff
17 Jul 20260.90 USD-6.9%1.34 USD1.53 USD-1.61-45.793.5MOff
10 Jul 20260.97 USD-6.2%1.37 USD1.53 USD-1.52-44.771.3MOff
3 Jul 20261.03 USD0.0%1.40 USD1.53 USD-1.43-40.691.7MOff
26 Jun 20261.03 USD6.8%1.42 USD1.54 USD-1.43-40.712.3MOff
19 Jun 20260.96 USD-9.0%1.44 USD1.54 USD-1.40-47.394.6MOff
12 Jun 20261.06 USD0.0%1.46 USD1.55 USD-1.27-41.171.9MOff
5 Jun 20261.06 USD-7.0%1.48 USD1.55 USD-1.09-40.362.4MOff
29 May 20261.14 USD1.8%1.49 USD1.55 USD-0.77-39.242.1MOff
22 May 20261.12 USD4.7%1.51 USD1.56 USD-0.51-39.073.0MOff
15 May 20261.07 USD-21.3%1.53 USD1.56 USD-0.24-41.587.0MOff
8 May 20261.36 USD-4.2%1.55 USD1.57 USD-0.19-26.593.3MOff
1 May 20261.42 USD-1.7%1.57 USD1.57 USD-0.43-19.443.8MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.